{"name":"Base Therapeutics (Shanghai) Co., Ltd.","slug":"base-therapeutics-shanghai-co-ltd","ticker":"","exchange":"","domain":"baseshanghai.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Tislelizumab，atezolizumab or sugemalimab","genericName":"Tislelizumab，atezolizumab or sugemalimab","slug":"tislelizumab-atezolizumab-or-sugemalimab","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Tislelizumab，atezolizumab or sugemalimab","genericName":"Tislelizumab，atezolizumab or sugemalimab","slug":"tislelizumab-atezolizumab-or-sugemalimab","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNTlVHbXpaNFRaTGxocDFLamFvZUFlMzMwMTBTM1djcFNaZkRzX2kwVnZ0Uk5pQzFsMDJOQWVBQXRJby1vQS12b092YndtNWxaZm5ROGhSTzk3V19EeDYwRzlUTkl5T1FuRTZTZlBiTWtpUlBBMkEzVXBtYWh2UVpFczFBWDA4QkFGcV9tRGg4MmQ0X0dwUENodm9EdjZtR2FraUo5ZE14WFJoZXlWb3pkaDNXUEdFODBPcXlKWWdZd0gwNEk1QnpoUV82NnJFLS10Q2EyaEtzbE01cGNSbGdJNg?oc=5","date":"2026-03-19","type":"pipeline","source":"Reuters","summary":"AstraZeneca to build cell therapy base, innovation centre in Shanghai - Reuters","headline":"AstraZeneca to build cell therapy base, innovation centre in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNSU8tRFAzc29ORlZnRzZJeDY2RlljUklUU2FlcUN6eG02OVVoTFg5ZkE0NWdPZll4endtY0tGb21qSExYYjBKbkRjTV9OTVFIOTJyNGhReFlNd3FxSkd2bHR0UllKNjc3bVNQTnBZYXVyejBQeXVubS1jbjNEQUliYUx0WkNvb3d6SUlWcUJlQjVnR0p1MG5rNUl2a1UxUDVmaFY5Qk1rOEhaZw?oc=5","date":"2026-03-06","type":"pipeline","source":"PR Newswire","summary":"CARsgen Therapeutics Announces 2025 Annual Results - PR Newswire","headline":"CARsgen Therapeutics Announces 2025 Annual Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQYWZBVGhIQXV1TUNPWkpMSnZFN1kwMXZmanNqYlF5RXd4eHlLV0N2M19KeXJ4ZGExUVBEQW9ScnRtZFBJeUM2MldjMGNzWEJPSEpiRGxUVlFmd05EQ3BXcHlFaTFkVjlSUkJKeWpFenh5UUJtY1J1NG42VnFpZjVyaGhaREI5QlYtMlN6U1NWd0dCSXNjeENkT2wwYjRjNG95OGZWRUhxazE?oc=5","date":"2026-02-13","type":"pipeline","source":"Contract Pharma","summary":"CARsgen to Expand Commercial Manufacturing Base in Shanghai - Contract Pharma","headline":"CARsgen to Expand Commercial Manufacturing Base in Shanghai","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOLUhNY0hDdW1oaE1MY0NGT3J2Z3lMcVo3NHp3d3dLcWVnZW1xSGNrTFlJQkNaREd1MVRmbjhaa2p0TjJEU3NtOU94cjVRenlWWUcwTDY4WGVhQl9aeG03LWZsRm4wNl90QVRJbkF4bjh3WTlUaHJpYzRTNGI4SW5qcHpKakNadEYzZGJaRnc4S2g0clZEa21CUElvLU9IWGRCNmdFNGlmLTNLOG9MdWtncGN6bG5BV3JtUnFrZTRmcXZlbXNhSUtMaDJDNDNNeEExZlVuV3Y3OFVZVlhS?oc=5","date":"2025-11-07","type":"pipeline","source":"BioPharma APAC","summary":"CorrectSequence Therapeutics Achieves World’s First Gene-Editing Success in Hyperlipidaemia Treatment - BioPharma APAC","headline":"CorrectSequence Therapeutics Achieves World’s First Gene-Editing Success in Hyperlipidaemia Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFAyMnRkdkdwUWJEX2d2Q1I0SEU4Sl9wQnVHTTlJRlJRYm9lbzFKQXhzQUk5X3ZNZDFiRUpfV0hpd2wxRGNXd2dkQzlCcHFNX2x6MEpzbVRENzR5c0lINFpz?oc=5","date":"2025-10-16","type":"pipeline","source":"Nature","summary":"A new kind of gateway to China’s biomedical boom - Nature","headline":"A new kind of gateway to China’s biomedical boom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxQU1lwTUx4aDRHdGJxS0EyWl9ZV2dtM1BxR1VfaVlBcmhVbHlGLTJnS3haYjExVndoNXJvLUxrekVOZDNIQUZiU1otNUt5OW5nY216WHFOalQ5VXZDZWZFVkhvRFU4c0RmNmFzX1ZSNF9lYkdaMjV5QlYyNDFkRGFpRUlHeHBuYWNFZGV4M1NzVjhaZ05PSzFPalMycHQ2YzVlNy12QVBjNU9lMXoyVmtXX0ZSa2xfUjRvNktpalhjYkR6YkpyRVBFWnNkWDhIVkhzMzNZU20yQTNBQUswSEo4ejRtbFllbzBic1JXS2RHVlRpUHlUMjZKYm1tZGk3cTlrYWpHQ2F6ei0xbHlHeUtTc1lWYmhDeE9VcE9nMk9QLTJFQjZSdUkzSEFtNjJnckpO?oc=5","date":"2025-08-26","type":"pipeline","source":"PR Newswire","summary":"High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient - PR Newswire","headline":"High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOeTZXMDZLQ2RrTmFlaEhSS0hpNzdyaEJvdHFPR0xObmV3dnVCMFFyQ2tSZHlwZEdOcEp5NkRpbkJJRkFoNGV5RGEzdzVZNkZfaGIwSkRFY21IOXdCTmFpOEpXRXQ3RVJzUWZQRUdFOWdIWjBVcWZDa2t2T3gzQUVYcnJmRFF3eGR2UlJEdlNOZk5qemJ2emliRmY3aw?oc=5","date":"2025-08-15","type":"pipeline","source":"CRISPR Medicine News","summary":"News: CMN Weekly (15 August 2025) - Your Weekly CRISPR Medicine News - CRISPR Medicine News","headline":"News: CMN Weekly (15 August 2025) - Your Weekly CRISPR Medicine News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBUQW9uM1dORElMRHI0eGZlVFhEcEdLWWJhSDdRakp3UTZYNzRfYjJBOThBdTI3Y0tqVzM5SUV3bkxBNjUydl9IZkNHblVfUHA4SFNaWTI2VTlzWVMzbjk2ckRnbGg5dlUtR3pPZWlhMTFyTks1c2c?oc=5","date":"2025-06-04","type":"pipeline","source":"ScienceDirect.com","summary":"Recent advances in therapeutic gene-editing technologies - ScienceDirect.com","headline":"Recent advances in therapeutic gene-editing technologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOVUZCQ2pBbHRXVXdJOXdXODkxYWpQbmw3NmlhZGRYWlJiQkZRTjZLeFJHTHNKaGlFR3ZPNWRxOHhpVzNmemdmMV9YenkyZDB0N0NGSW9yTkVidnI4WDJGUTJieHhhODZENzJTTXdEeGtnNmR6dGhNMnRTbnhCcGt2UUw0dVB4YnAxUnZhWFNpdw?oc=5","date":"2025-03-24","type":"regulatory","source":"BioPharma Dive","summary":"Verve gets FDA green light to expand base editing trial into US - BioPharma Dive","headline":"Verve gets FDA green light to expand base editing trial into US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQVVRYVERUMnhPdkg0X0xTOEVGXzdVU3Ezc1dTN3VzalhGeGpyYzNaM2JTZVNLTHNfZ1FRd0xfVjA3MFRrU2xaalN3QVM2X3ktREtjMlVrc2NtZ1JaTmNUTjh1Y3Ziczg0ejZlblEyVlRYVjFiVHFheHR5Z1NqckxvMmI0WU93YlJ6SVktMmdYZWNSc3k5ZnNWdnNDREUyNjQ2V1FUd21aaDhYY1VBSjBn?oc=5","date":"2024-08-27","type":"pipeline","source":"Fierce Biotech","summary":"YolTech sells China rights to cholesterol gene editing therapy to Salubris for $29M - Fierce Biotech","headline":"YolTech sells China rights to cholesterol gene editing therapy to Salubris for $29M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNdmxJbG9ycVpnLVV5VW13Zi1aOGpaVzhBTHBLak9yWkxGWDkwV0VJbFk2UUx3dzRwMm1OWDN5OFBlZ0VtanRWV01fUFRoNnZHV0JwSHhGMi1RNkI1Y0pYTXM1cGNJOWFlXzcwZmhMblZKRl9NRm8zZml5LXI3T010dHJtZVJ0RDVzbVNfMFpyU1I2Y0YwWmVpZHo2X3FBVE1wRWtvaHlHMlFwUGU2dzJzRkFrd2pXSjdzTFBTaW1yZk80c0RZeEdKMVNRQzd0YTd0Xy1ZVXJ6bUQ5Z3dyalY5YmU0b0lFMldNRlg5TUoyUUh3MzNFNUZvWGx0SQ?oc=5","date":"2024-08-06","type":"pipeline","source":"BioSpace","summary":"OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics - BioSpace","headline":"OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by Correc","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}